Cargando…

CHILDREN WITH MULTIPLE CONGENITAL DEFECTS: WHAT ARE THE LIMITS BETWEEN THERAPEUTIC OBSTINACY AND THE TREATMENT OF UNCERTAIN BENEFIT?

OBJECTIVE: Therapeutic approach of children with multiple malformations poses many dilemmas, making it difficult to build a line between the treatment of uncertain benefit and therapeutic obstinacy. The aim of this paper was to highlight possible sources of uncertainty in the decision-making process...

Descripción completa

Detalles Bibliográficos
Autores principales: Pastura, Patricia Souza Valle Cardoso, Land, Marcelo Gerardin Poirot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade de Pediatria de São Paulo 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417797/
https://www.ncbi.nlm.nih.gov/pubmed/28977304
http://dx.doi.org/10.1590/1984-0462/;2017;35;1;00004
_version_ 1783233957663342592
author Pastura, Patricia Souza Valle Cardoso
Land, Marcelo Gerardin Poirot
author_facet Pastura, Patricia Souza Valle Cardoso
Land, Marcelo Gerardin Poirot
author_sort Pastura, Patricia Souza Valle Cardoso
collection PubMed
description OBJECTIVE: Therapeutic approach of children with multiple malformations poses many dilemmas, making it difficult to build a line between the treatment of uncertain benefit and therapeutic obstinacy. The aim of this paper was to highlight possible sources of uncertainty in the decision-making process, for this group of children. CASE DESCRIPTION: An 11-month-old boy, born with multiple birth defects and abandoned by his parents, has never been discharged home. He has complex congenital heart disease, main left bronchus stenosis and imperforate anus. He is under technological support and has gone through many surgical procedures. The complete correction of the cardiac defect seems unlikely, and every attempt to wean the ventilator has failed. COMMENTS: The first two main sources of uncertainty in the management of children with multiple birth defects are related to an uncertain prognosis. There is a lack of empirical data, due to the multiple possibilities of anatomic or functional organ involvement, with few similar cases described. Prognosis is also unpredictable for neuro-developmental evolution, as well as the capacity for the development and regeneration of other organs. Another source of uncertainty is how to qualify the present and future life as worth living, by weighing the costs and benefits. The fourth source of uncertainty is who has the decision: physicians or parents? Finally, if a treatment is defined futile then, how to limit support? No single framework exists to help these delicate decision-making processes. We propose, then, that physicians should be committed to develop their own perception skills in order to understand patient’s manifestations of needs and family values.
format Online
Article
Text
id pubmed-5417797
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Sociedade de Pediatria de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-54177972017-05-24 CHILDREN WITH MULTIPLE CONGENITAL DEFECTS: WHAT ARE THE LIMITS BETWEEN THERAPEUTIC OBSTINACY AND THE TREATMENT OF UNCERTAIN BENEFIT? Pastura, Patricia Souza Valle Cardoso Land, Marcelo Gerardin Poirot Rev Paul Pediatr Case Reports OBJECTIVE: Therapeutic approach of children with multiple malformations poses many dilemmas, making it difficult to build a line between the treatment of uncertain benefit and therapeutic obstinacy. The aim of this paper was to highlight possible sources of uncertainty in the decision-making process, for this group of children. CASE DESCRIPTION: An 11-month-old boy, born with multiple birth defects and abandoned by his parents, has never been discharged home. He has complex congenital heart disease, main left bronchus stenosis and imperforate anus. He is under technological support and has gone through many surgical procedures. The complete correction of the cardiac defect seems unlikely, and every attempt to wean the ventilator has failed. COMMENTS: The first two main sources of uncertainty in the management of children with multiple birth defects are related to an uncertain prognosis. There is a lack of empirical data, due to the multiple possibilities of anatomic or functional organ involvement, with few similar cases described. Prognosis is also unpredictable for neuro-developmental evolution, as well as the capacity for the development and regeneration of other organs. Another source of uncertainty is how to qualify the present and future life as worth living, by weighing the costs and benefits. The fourth source of uncertainty is who has the decision: physicians or parents? Finally, if a treatment is defined futile then, how to limit support? No single framework exists to help these delicate decision-making processes. We propose, then, that physicians should be committed to develop their own perception skills in order to understand patient’s manifestations of needs and family values. Sociedade de Pediatria de São Paulo 2017-02-20 2017 /pmc/articles/PMC5417797/ /pubmed/28977304 http://dx.doi.org/10.1590/1984-0462/;2017;35;1;00004 Text en http://creativecommons.org/licenses/by/4.0/ Este é um artigo publicado em acesso aberto sob uma licença Creative Commons
spellingShingle Case Reports
Pastura, Patricia Souza Valle Cardoso
Land, Marcelo Gerardin Poirot
CHILDREN WITH MULTIPLE CONGENITAL DEFECTS: WHAT ARE THE LIMITS BETWEEN THERAPEUTIC OBSTINACY AND THE TREATMENT OF UNCERTAIN BENEFIT?
title CHILDREN WITH MULTIPLE CONGENITAL DEFECTS: WHAT ARE THE LIMITS BETWEEN THERAPEUTIC OBSTINACY AND THE TREATMENT OF UNCERTAIN BENEFIT?
title_full CHILDREN WITH MULTIPLE CONGENITAL DEFECTS: WHAT ARE THE LIMITS BETWEEN THERAPEUTIC OBSTINACY AND THE TREATMENT OF UNCERTAIN BENEFIT?
title_fullStr CHILDREN WITH MULTIPLE CONGENITAL DEFECTS: WHAT ARE THE LIMITS BETWEEN THERAPEUTIC OBSTINACY AND THE TREATMENT OF UNCERTAIN BENEFIT?
title_full_unstemmed CHILDREN WITH MULTIPLE CONGENITAL DEFECTS: WHAT ARE THE LIMITS BETWEEN THERAPEUTIC OBSTINACY AND THE TREATMENT OF UNCERTAIN BENEFIT?
title_short CHILDREN WITH MULTIPLE CONGENITAL DEFECTS: WHAT ARE THE LIMITS BETWEEN THERAPEUTIC OBSTINACY AND THE TREATMENT OF UNCERTAIN BENEFIT?
title_sort children with multiple congenital defects: what are the limits between therapeutic obstinacy and the treatment of uncertain benefit?
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417797/
https://www.ncbi.nlm.nih.gov/pubmed/28977304
http://dx.doi.org/10.1590/1984-0462/;2017;35;1;00004
work_keys_str_mv AT pasturapatriciasouzavallecardoso childrenwithmultiplecongenitaldefectswhatarethelimitsbetweentherapeuticobstinacyandthetreatmentofuncertainbenefit
AT landmarcelogerardinpoirot childrenwithmultiplecongenitaldefectswhatarethelimitsbetweentherapeuticobstinacyandthetreatmentofuncertainbenefit